4162.TWO · PEI
Taiwan · RS rating 35 · As of 2026-10-08
| Price | 57.20 TWD |
|---|---|
| 1-day change | +2.5% |
| RS rating (overall / 1M / 3M / 12M) | 35 / 51 / 33 / 36 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 31 / 18 / 36 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | -2.1% |
| Sales growth Q/Q | +7.6% |
| Distance from 52-week high | +22.5% |
| Market cap (USD) | $249.3M |